Waters Corporation ($WAT) Stock Forecast: Up 5.0% Today

What is Waters Corporation?

Waters Corporation (WAT) is a leading provider of analytical instruments for the pharmaceutical, life sciences, and environmental industries. Today, the stock had a strong bullish movement in the market.

Why is Waters Corporation going up?

WAT stock is up 5.0% on Feb 18, 2026 17:21

• Waters Corporation's bullish movement can be attributed to the launch of their new 1 mm I.D. liquid chromatography (LC) columns with MaxPeak Premier Technology. This innovation promises higher sensitivity, reduced sample usage by 75%, and decreased solvent consumption by up to four times compared to traditional columns, catering to high-throughput bioseparations and pharmaceutical applications.
• The positive market sentiment towards Waters Corporation could also be influenced by the overall growth projections of the Gas Chromatography Systems Market, which is expected to reach US$7.20 billion by 2032. This indicates a rising demand for advanced analytical instrumentation, benefiting companies like Waters Corporation.
• The emphasis on technological advancements by key players in the gas chromatography market, such as Thermo Fisher Scientific and Agilent Technologies, further highlights the potential for growth and innovation in the sector. Waters Corporation's introduction of cutting-edge technology aligns with this trend, likely contributing to the bullish movement of their stock.
• Waters Corporation's focus on enhancing sensitivity, sample recovery, and data quality through their new LC columns positions them well to capitalize on the increasing demand for analytical solutions in various industries, potentially driving further positive momentum in their stock performance.

WAT Price Chart

WAT Technical Analysis

WAT News

Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

Waters Corporation has launched new 1 mm I.D. liquid chromatography (LC) columns with MaxPeak Premier Technology for its ACQUITY™, BioResolve™, and GTxResolve™ Column brands. These columns offer up to two times higher sensitivity, use 75% less sample, and reduce solvent consumption by up to four times compared to traditional columns, benefiting high-throughput bioseparations, DMPK, and 'omics applications. This innovation aims to accelerate and simplify the development of life-changing therapies by improving sample recovery and data quality, particularly in areas with limited sample availability.

https://finviz.com/news/312507/waters-introduces-next-generation-microflow-lc-columns-with-maxpeak-premier-technology-delivering-higher-sensitivity-with-lower-sample-and-solvent-usage

Gas Chromatography Systems Market to Reach US$7.20 Billion

The global Gas Chromatography Systems Market is projected to reach US$7.20 billion by 2032, growing at an 8.8% CAGR from 2025 to 2032, up from US$3,668.75 million in 2024. This growth is driven by increasing demand for advanced analytical instrumentation in various sectors like environmental analysis, pharmaceuticals, and food safety, with North America leading the market. Key players like Thermo Fisher Scientific, Agilent Technologies, and Shimadzu Corporation are advancing the market through technological innovations in detector sensitivity, automation, AI integration, and the development of portable systems.

https://www.openpr.com/news/4394153/gas-chromatography-systems-market-to-reach-us-7-20-billion

Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

Waters Corporation has launched new 1 mm I.D. microflow liquid chromatography (LC) columns featuring MaxPeak Premier Technology, designed to enhance sensitivity and reduce sample and solvent usage. These columns aim to improve analytical performance in various applications like bioanalysis, pharmaceutical development, and 'omics, especially where sample availability is limited. The technology minimizes nonspecific adsorption, leading to higher recovery, sharper peaks, and more reproducible results, while also supporting environmental goals by reducing solvent consumption.

https://finance.yahoo.com/news/waters-introduces-next-generation-microflow-130000023.html

New Waters microflow columns use 75% less sample in drug R&D

Waters Corporation has launched new 1 mm I.D. microflow LC columns with MaxPeak Premier Technology, designed for ACQUITY, BioResolve, and GTxResolve brands. These columns offer up to twice the sensitivity, use 75% less sample, and reduce solvent consumption by up to four times compared to 2.1 mm I.D. columns. This innovation aims to address challenges in bioanalysis, pharmaceutical development, and 'omics applications by improving recovery for various molecules while conserving precious resources.

https://www.stocktitan.net/news/WAT/waters-introduces-next-generation-microflow-lc-columns-with-max-peak-svd9eud3p4k1.html

5 Must-Read Analyst Questions From BD's Q4 Earnings Call

BD (Becton, Dickinson and Company) reported strong Q4 results with revenue and EPS exceeding analyst estimates, driven by growth in biologic drug delivery, advanced tissue regeneration, and pharmacy automation. Despite challenges from China and vaccine-related pressures, the company maintained focus on investments in growth platforms and productivity. Analyst questions highlighted concerns about future guidance, portfolio changes, and the long-term outlook for GLP-1 devices, with management providing clarifying responses.

https://finviz.com/news/311885/5-must-read-analyst-questions-from-bds-q4-earnings-call

Trending Today

Ethereum ($ETH) Crypto Forecast: Down 5.5% Today

Dogecoin ($DOGE) Crypto Forecast: Down 5.3% Today

Waters Corporation Price History

01.10.2024 - WAT Stock was up 16.7%

• Waters Corporation (WAT) had a strong bullish movement today.
• The stock beat Q3 earnings and revenue estimates by 9.33% and 3.65% respectively, indicating strong financial performance.
• Expectations of beating earnings estimates further fueled investor optimism, driving the stock higher.
• The positive results and outlook suggest that Waters Corporation is on a solid growth trajectory, attracting more investors to the stock.

13.01.2026 - WAT Stock was up 5.3%

• Waters Corporation (WAT) experienced a strong bullish movement today, potentially driven by the following factors:
• Despite a recent 19% decline in the stock price, analysts are optimistic about a turnaround, with the stock being in oversold territory and showing signs of rebound potential.
• The company reported robust Q4 and full-year 2025 results, with strong sales and earnings, as well as providing optimistic guidance for 2026.
• Waters' recent acquisition of BD Biosciences and Diagnostic Solutions is expected to contribute significantly to revenue growth and synergies, boosting investor confidence in the company's future prospects.
• The positive sentiment surrounding Waters Corporation contrasts with the news about another company, which has been undergoing changes such as the sale of its Life Sciences business and facing mixed analyst reactions, potentially diverting investor attention towards WAT's more promising outlook.

06.00.2026 - WAT Stock was up 5.2%

• Received an Outperform rating with projections of significant EPS growth by 2030 due to synergies from the BD Biosciences and Diagnostics Solutions acquisition.
• Strong Q3 2025 financial results surpassed analyst expectations, leading to multiple upgrades and price target increases.
• Estimated intrinsic value suggests the current share price is trading at similar levels to fair value, indicating a balanced valuation.
• The combination of favorable analyst ratings, strategic acquisitions, and solid financial performance likely contributed to the bullish movement in the stock today.

05.00.2026 - WAT Stock was up 1.7%

• An analyst initiated coverage on Waters Corp with an Outperform rating, referencing synergies from the BD acquisition as a primary growth driver, leading to a positive market sentiment.
• The alignment of Waters' intrinsic value with its current share price suggests investors view the stock as fairly valued, contributing to the bullish momentum.
• Despite a challenging year for capital spending, Waters Corp's strategic shift towards recurring revenue streams and focus on high-value biopharma and QA/QC workflows have instilled confidence among analysts, supporting the bullish trend.
• The company's disciplined approach to rebuilding, integration of core hardware with software and data analytics, and emphasis on becoming a resilient platform provider have positioned it well for potential future growth, further boosting investor optimism and driving the bullish market movement.

15.06.2025 - WAT Stock was down 5.8%

• The bearish movement in Waters Corporation's stock today can be attributed to the market's reaction to the collaboration news with Becton Dickinson.
• Investors might be concerned about the long-term implications of the $17.5B deal and the ambitious revenue targets set for 2030, which could lead to uncertainty and selling pressure on Waters' stock.
• The market might be interpreting the partnership as a potential risk factor for Waters' standalone growth prospects, leading to a pessimistic sentiment among investors and triggering the bearish movement in the stock price.
• Investors may be waiting for more clarity on how the collaboration will impact Waters' financials and strategic direction before reassessing the stock's valuation and growth potential.

04.10.2025 - WAT Stock was up 6.7%

• Waters Corporation (WAT) exceeded Q3 earnings and revenue estimates, indicating strong financial performance.
• The positive surprises in earnings and revenue suggest that the company's products and services are in high demand.
• Investors are likely optimistic about Waters' future prospects, leading to a bullish movement in the stock price.
• The strong quarterly results may attract more investors and analysts' attention, further boosting the stock's performance in the near term.

14.06.2025 - WAT Stock was down 4.6%

• The decline in Waters' stock value could be linked to Becton Dickinson's optimistic projections for its diagnostics business, potentially overshadowing Waters' own performance forecasts.
• Investor apprehension regarding the competitive dynamics within the diagnostics industry may have intensified following the announcement of the merged company's ambitious revenue and EBITDA goals for 2030.
• The market's response might reflect concerns over the perceived competitive challenge posed by Becton Dickinson's growth strategies, prompting a selloff of Waters' shares as market participants reassess their sectoral investments.
• This development likely influenced investor sentiment towards viewing Becton Dickinson as a more appealing healthcare industry investment opportunity, thereby exerting a negative impact on Waters' stock value.

18.01.2026 - WAT Stock was up 5.0%

• Waters Corporation's bullish movement can be attributed to the launch of their new 1 mm I.D. liquid chromatography (LC) columns with MaxPeak Premier Technology. This innovation promises higher sensitivity, reduced sample usage by 75%, and decreased solvent consumption by up to four times compared to traditional columns, catering to high-throughput bioseparations and pharmaceutical applications.
• The positive market sentiment towards Waters Corporation could also be influenced by the overall growth projections of the Gas Chromatography Systems Market, which is expected to reach US$7.20 billion by 2032. This indicates a rising demand for advanced analytical instrumentation, benefiting companies like Waters Corporation.
• The emphasis on technological advancements by key players in the gas chromatography market, such as Thermo Fisher Scientific and Agilent Technologies, further highlights the potential for growth and innovation in the sector. Waters Corporation's introduction of cutting-edge technology aligns with this trend, likely contributing to the bullish movement of their stock.
• Waters Corporation's focus on enhancing sensitivity, sample recovery, and data quality through their new LC columns positions them well to capitalize on the increasing demand for analytical solutions in various industries, potentially driving further positive momentum in their stock performance.

12.01.2026 - WAT Stock was down 5.3%

• Waters Corporation (WAT) experienced a bearish movement following a price target downgrade by an analyst from Wells Fargo.
• The downgrade may be linked to the upcoming merger with BD's life science and diagnostics business, leading to investor uncertainty about the combined entity's future prospects.
• Despite the downgrade, analysts from Guggenheim and HSBC have issued positive ratings and higher price targets, indicating varying opinions on the merger's potential success.
• Investor behavior suggests a keen interest in monitoring the merger's developments and its possible impact on Waters Corporation's growth in the competitive life sciences industry.

12.01.2026 - WAT Stock was down 5.5%

• Waters Corporation's stock slipped despite beating Q4 expectations, indicating investor disappointment in the company's outlook. This could have contributed to the bearish movement.
• The news of Becton, Dickinson and Company (BDX) raising its price target and reporting strong Q1 results might have shifted investor focus towards BDX, leading to a relative sell-off of WAT shares.
• The merger of BD's Biosciences & Diagnostics business with Waters Corporation could have caused uncertainty among investors regarding the future prospects of Waters Corporation, impacting its stock performance negatively.
• Despite Waters Corporation's recent challenges, focusing on strategic growth opportunities and improving outlook could help regain investor confidence and stabilize the stock price in the future.

06.04.2025 - WAT Stock was down 5.0%

• Waters (WAT) beat earnings and revenue estimates for the first quarter of 2025 but experienced a strong bearish movement.
• The market's negative reaction may be related to concerns about future growth prospects or guidance from the company.
• Investors may have anticipated higher performance or guidance, resulting in a stock sell-off.
• Macroeconomic factors or challenges specific to the industry could be overshadowing the positive earnings results, causing the bearish movement in WAT's stock price.

01.07.2025 - WAT Stock was down 6.4%

• The bearish movement in WAT today could be due to profit-taking by investors after a period of strong growth.
• Despite the positive expectations for the upcoming earnings report, market sentiment may have shifted, leading to a sell-off of WAT shares.
• It's possible that some investors are cautious about the company's future outlook or there may be broader market concerns impacting WAT's stock price.
• Overall, the bearish movement in WAT today may be a short-term correction rather than a reflection of the company's long-term prospects.